statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Titoli in rialzo
Le azioni di Kineta (NASDAQ:KA) hanno guadagnato l'11,21% a 0,60 dollari durante la sessione after-market di luned .
Le azioni di Finch Therapeutics Gr (NASDAQ:FNCH) sono salite...

12 titoli sanitari in movimento, after-market del 08/04/2024

AIM ImmunoTech (NYSE:AIM - Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the...

Finch Therapeutics Group (NASDAQ:FNCH) versus AIM ImmunoTech (NYSE:AIM) Head-To-Head Survey

Finch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Free Report) Director Jeffery A. Smisek sold 6,642 shares of the company's stock in a transaction that occurred on Thursday, March 28th. The shares...

Insider Selling: Finch Therapeutics Group, Inc. (NASDAQ:FNCH) Director Sells $17,069.94 in Stock

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.

Finch Therapeutics Group Inc

Volume	59,044.00
52-Wk High	$16.74
52-Wk Low	$1.86

Period	Estimated	Reported	Surprise	Result
Q3'23	-$5.67	--	--	N/A
Q2'23	-$4.50	--	--	N/A
Q1'23	-$2.70	-$39.90	-1377.78%	MISSED
Q4'22	-$9.90	-$16.80	-69.70%	MISSED
Q3'22	-$12.60	-$0.85	93.25%	BEAT

FNCH Finch Therapeutics Group Inc

About

Feed

News

Sentiment

Earnings

Fundamentals